Drs. Herriman, Sharp, and Oethinger will address problems within the United States healthcare system, which cause 99,000 Americans to die from hospital acquired infections each year, Feb. 23, 2016
SUNNYVALE, Calif., Feb. 16, 2016 — Margret Oethinger, MD, Ph.D., Medical Director of Microbiology at Providence Health & Services in Oregon, and Susan E. Sharp, Ph.D., DABMM, FAAM, Regional Director of Microbiology and the Molecular Infectious Disease Laboratories in the Department of Pathology for Kaiser Permanente Northwest in Oregon and President-Elect of the American Society for Microbiology will join L. Eleanor J. Herriman, MD, MBA, Chief Medical Informatics Officer at Viewics in a live, online panel discussion, “Tackling the U.S. Healthcare System’s Infectious Disease Management Problem,” on Feb. 23, 2016 at 10 am Pacific Time/1 pm Eastern time. The three doctors will discuss the current state of infectious disease diagnosis in the U.S. and what can be done to improve it.
The United States’ healthcare system has a serious infectious disease management problem. Nearly two million Americans develop nosocomial, or hospital-acquired, infections each year, and of those infected, nearly 99,000 die. Antibiotic-resistant bacteria account for at least 23,000 of these deaths, and many more people die from conditions that were complicated by an antibiotic-resistant infection. Delays in pathogen identification in critical hospital infections such as sepsis have been shown to lead to increased mortality and unnecessary expenses. And while community health systems have long had to grapple with infectious outbreaks of influenza and meningitis, now they also have to fight healthcare-acquired infections and multidrug resistant bacteria as well.
This panel discussion will be of particular interest to health system leaders who want to explore approaches to reducing antibiotic resistance, rapidly identifying pathogens in their patients, and controlling infectious disease in the hospital and the community. One approach to be discussed will be the role of advanced molecular diagnostics in the clinical microbiology laboratory.
For full details about the event and free registration, click here
- Ventola CL. The Antibiotic Resistance Crisis: Part 1: Causes and Threats. Pharmacy and Therapeutics. 2015;40(4):277-283. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4378521/
- Centers for Disease Control and Prevention. Antibiotic Resistance Threats in the United States, 2013. http://www.cdc.gov/drugresistance/threat-report-2013/
- Matthew P. Rubach and Kimberly E. Hanson. ID Learning Unit—Diagnostics Update: Current Laboratory Methods for Rapid Pathogen Identification in Patients With Bloodstream Infections. Open Forum Infect Dis (Fall 2015) 2 (4) http://www.ncbi.nlm.nih.gov/pubmed/26719845
Viewics provides unprecedented access to disparate healthcare data to surface actionable intelligence and empower data-driven decision-making. Through expertise and focus on healthcare analytics, Viewics delivers proprietary, best-in-class technology for data extraction, cleansing, and transformation to quickly unlock insights that deliver invaluable clinical and financial impact, while reducing the burden on information technology. For more information, visit www.viewics.com.